Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00186823 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Acute Lymphocytic (ALL)
Leukemia, Myeloid, Acute(AML)
Leukemia, Myeloid, Chronic(CML)
Juvenile Myelomonocytic Leukemia(JMML)
Hemoglobinuria, Paroxysmal Nocturnal (PNH)
Lymphoma, Non-Hodgkin (NHL)
Myelodysplastic Syndrome (MDS)

Interventions

DEVICE: Miltenyi Biotec CliniMACS
PROCEDURE: Stem Cell Transplantation
DRUG: TBI, systemic chemotherapy and antibodies as follows:

Sponsor

St. Jude Children's Research Hospital